Filing Details

Accession Number:
0001104659-20-021844
Form Type:
13G Filing
Publication Date:
2020-02-14 16:26:01
Filed By:
D E Shaw
Company:
Assertio Therapeutics Inc (NASDAQ:ASRT)
Filing Date:
2020-02-14
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
D. E. Shaw Co. 0 4,357,385 0 4,506,585 4,506,585 5.6%
David E. Shaw 0 4,357,385 0 4,506,585 4,506,585 5.6%
Filing
 

 

SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C. 20549

 

SCHEDULE 13G 

(Amendment No. 1)

 

 

Under the Securities Exchange Act of 1934

 

 

Assertio Therapeutics, Inc.

(Name of Issuer)

 

 

Common Stock, $0.0001 par value

(Title of Class of Securities)

 

 

04545L107

(CUSIP Number)

 

 

December 31, 2019

(Date of Event Which Requires Filing of this Statement)

 

Check the following box to designate the rule pursuant to which the Schedule is filed:

 

¨Rule 13d-1(b)
xRule 13d-1(c)
¨Rule 13d-1(d)

 

*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

 

CUSIP No. 04545L107

 

  1.

Names of Reporting Persons

I.R.S. Identification Nos. of above persons (entities only)

D. E. Shaw & Co., L.P.

13-3695715

 

  2. Check the Appropriate Box if a Member of a Group (See Instructions)
    (a) [     ]
   

(b)

 

[     ]
  3.

SEC Use Only

 

  4.

Citizenship or Place of Organization

Delaware

 

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person With

5.

Sole Voting Power

 

 

-0-

      6.

Shared Voting Power

4,357,385

 

      7.

Sole Dispositive Power

-0-

 

      8.

Shared Dispositive Power

4,506,585

 

  9.

Aggregate Amount Beneficially Owned by Each Reporting Person

4,506,585

 

  10.

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [     ]

 

  11.

Percent of Class Represented by Amount in Row (9)

5.6%

 

  12.

Type of Reporting Person (See Instructions)

IA, PN

 

 

 

CUSIP No. 04545L107

 

  1.

Names of Reporting Persons

I.R.S. Identification Nos. of above persons (entities only)

David E. Shaw

 

  2. Check the Appropriate Box if a Member of a Group (See Instructions)
    (a) [     ]
   

(b)

 

[     ]
  3.

SEC Use Only

 

  4.

Citizenship or Place of Organization

United States

 

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person With

5.

Sole Voting Power

 

 

-0-

      6.

Shared Voting Power

4,357,385

 

      7.

Sole Dispositive Power

-0-

 

      8.

Shared Dispositive Power

4,506,585

 

  9.

Aggregate Amount Beneficially Owned by Each Reporting Person

4,506,585

 

  10.

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [     ]

 

  11.

Percent of Class Represented by Amount in Row (9)

5.6%

 

  12.

Type of Reporting Person (See Instructions)

IN

 

 

 

 

 

Item 1.
  (a) Name of Issuer
    Assertio Therapeutics, Inc.
   
  (b) Address of Issuer's Principal Executive Offices
   

100 South Saunders Road, Suite 300

Lake Forest, IL 60045

   
Item 2.
  (a) Name of Person Filing
   

D. E. Shaw & Co., L.P.

David E. Shaw

   
  (b) Address of Principal Business Office or, if none, Residence
   

The business address for each reporting person is:

1166 Avenue of the Americas, 9th Floor

New York, NY 10036

   
  (c) Citizenship
   

D. E. Shaw & Co., L.P. is a limited partnership organized under the laws of the state of Delaware.

David E. Shaw is a citizen of the United States of America.

   
  (d) Title of Class of Securities
    Common Stock, $0.0001 par value
   
  (e) CUSIP Number
    04545L107
   
Item 3.

If this statement is filed pursuant to Rule 13d-1(b) or 13d-2(b) or (c), check whether the person filing is a:

 

Not Applicable

 

Item 4.

Ownership

 

As of December 31, 2019:

 

(a)Amount beneficially owned:
 

 

D. E. Shaw & Co., L.P.:

 

 

4,506,585 shares

This is composed of (i) 1,539,600 shares in the name of D. E. Shaw Valence Portfolios, L.L.C., (ii) 498,072 shares in the name of D. E. Shaw Oculus Portfolios, L.L.C., and (iii) 2,468,913 shares under the management of D. E. Shaw Investment Management, L.L.C.

 

 

David E. Shaw:

 

4,506,585 shares

This is composed of (i) 1,539,600 shares in the name of D. E. Shaw Valence Portfolios, L.L.C., (ii) 498,072 shares in the name of D. E. Shaw Oculus Portfolios, L.L.C., and (iii) 2,468,913 shares under the management of D. E. Shaw Investment Management, L.L.C.

 

(b)Percent of class:
  D. E. Shaw & Co., L.P.: 5.6%
  David E. Shaw: 5.6%


 


(c)Number of shares to which the person has:
(i)Sole power to vote or to direct the vote:
  D. E. Shaw & Co., L.P.: -0- shares
  David E. Shaw: -0- shares   

 

(ii)Shared power to vote or to direct the vote:
  D. E. Shaw & Co., L.P.: 4,357,385 shares     
  David E. Shaw: 4,357,385 shares   

 

(iii)Sole power to dispose or to direct the disposition of:
  D. E. Shaw & Co., L.P.: -0- shares   
  David E. Shaw: -0- shares   

 

(iv)Shared power to dispose or to direct the disposition of:
  D. E. Shaw & Co., L.P.: 4,506,585 shares   
  David E. Shaw: 4,506,585 shares   

 

David E. Shaw does not own any shares directly. By virtue of David E. Shaw’s position as President and sole shareholder of D. E. Shaw & Co., Inc., which is the general partner of D. E. Shaw & Co., L.P., which in turn is the investment adviser of D. E. Shaw Valence Portfolios, L.L.C. and D. E. Shaw Oculus Portfolios, L.L.C. and the managing member of D. E. Shaw Investment Management, L.L.C., and by virtue of David E. Shaw’s position as President and sole shareholder of D. E. Shaw & Co. II, Inc., which is the managing member of D. E. Shaw & Co., L.L.C., which in turn is the manager of D. E. Shaw Valence Portfolios, L.L.C. and D. E. Shaw Oculus Portfolios, L.L.C., David E. Shaw may be deemed to have the shared power to vote or direct the vote of 4,357,385 shares, and the shared power to dispose or direct the disposition of 4,506,585 shares, the 4,506,585 shares as described above constituting 5.6% of the outstanding shares and, therefore, David E. Shaw may be deemed to be the beneficial owner of such shares. David E. Shaw disclaims beneficial ownership of such 4,506,585 shares.

 

Item 5. Ownership of Five Percent or Less of a Class

Not Applicable

 

Item 6. Ownership of More than Five Percent on Behalf of Another Person.

Not Applicable

 

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.

Not Applicable

 

Item 8. Identification and Classification of Members of the Group

Not Applicable

 

Item 9. Notice of Dissolution of Group

Not Applicable

 

Item 10. Certification

By signing below, each of D. E. Shaw & Co., L.P. and David E. Shaw certify that, to the best of such reporting person’s knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having such purposes or effect.

 

 

 

SIGNATURE

 

After reasonable inquiry and to the best of their knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct. A Power of Attorney, dated March 1, 2017, granted by David E. Shaw in favor of Nathan Thomas, is attached hereto.

 

Dated: February 14, 2020

 

 

 

D. E. Shaw & Co., L.P.

   
  By: /s/ Nathan Thomas
    Nathan Thomas
   

Chief Compliance Officer

 

 

 

David E. Shaw

   
  By: /s/ Nathan Thomas
    Nathan Thomas
   

Attorney-in-Fact for David E. Shaw